Establishment Labs Hldgs Analyst Ratings
Establishment Labs Hldgs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/08/2023 | 86.92% | Mizuho | $80 → $50 | Maintains | Buy |
08/31/2023 | 180.37% | JP Morgan | → $75 | Initiates Coverage On | → Overweight |
07/21/2023 | 232.71% | Stephens & Co. | → $89 | Reiterates | Overweight → Overweight |
06/29/2023 | 195.33% | Citigroup | → $79 | Initiates Coverage On | → Buy |
04/21/2023 | 232.71% | Stephens & Co. | → $89 | Reiterates | → Overweight |
04/21/2023 | 311.21% | Mizuho | $95 → $110 | Maintains | Buy |
04/17/2023 | 292.52% | BTIG | $100 → $105 | Maintains | Buy |
02/28/2023 | 232.71% | Stephens & Co. | $87 → $89 | Maintains | Overweight |
01/24/2023 | 255.14% | Mizuho | $70 → $95 | Maintains | Buy |
12/28/2022 | 225.23% | Stephens & Co. | $90 → $87 | Maintains | Overweight |
10/14/2022 | 236.45% | Stephens & Co. | → $90 | Reinstates | → Overweight |
10/13/2022 | 161.68% | Mizuho | → $70 | Initiates Coverage On | → Buy |
10/07/2022 | 273.83% | BTIG | $90 → $100 | Maintains | Buy |
08/24/2022 | 300% | B. Riley Securities | → $107 | Initiates Coverage On | → Buy |
08/09/2022 | 142.99% | Goldman Sachs | $57 → $65 | Maintains | Neutral |
06/24/2022 | 236.45% | BTIG | $105 → $90 | Maintains | Buy |
05/11/2022 | 113.08% | Goldman Sachs | $67 → $57 | Maintains | Neutral |
04/22/2022 | 311.21% | BTIG | $95 → $110 | Maintains | Buy |
03/21/2022 | 150.47% | Goldman Sachs | $78 → $67 | Maintains | Neutral |
11/10/2021 | 236.45% | Stephens & Co. | $88 → $90 | Maintains | Overweight |
08/03/2021 | 191.59% | Goldman Sachs | $68 → $78 | Maintains | Neutral |
06/23/2021 | 228.97% | BTIG | $82 → $88 | Maintains | Buy |
02/10/2021 | 199.07% | Cowen & Co. | $60 → $80 | Maintains | Outperform |
05/14/2020 | -25.23% | Goldman Sachs | → $20 | Initiates Coverage On | → Neutral |
03/23/2020 | -14.02% | Stephens & Co. | $30 → $23 | Maintains | Overweight |
03/17/2020 | 30.84% | BTIG | $40 → $35 | Maintains | Buy |
06/28/2019 | 8.41% | Wells Fargo | → $29 | Initiates Coverage On | → Outperform |
06/07/2019 | 38.32% | Stephens & Co. | → $37 | Initiates Coverage On | → Overweight |
日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
---|---|---|---|---|---|
11/08/2023 | 86.92% | 瑞穗市 | 80 美元 → 50 美元 | 維護 | 買 |
08/31/2023 | 180.37% | 摩根大通 | → 75 美元 | 啓動覆蓋範圍開啓 | → 超重 |
07/21/2023 | 232.71% | Stephens & Co. | → 89 美元 | 重申 | 超重 → 超重 |
06/29/2023 | 195.33% | 花旗集團 | → 79 美元 | 啓動覆蓋範圍開啓 | → 購買 |
04/21/2023 | 232.71% | Stephens & Co. | → 89 美元 | 重申 | → 超重 |
04/21/2023 | 311.21% | 瑞穗市 | 95 美元 → 110 美元 | 維護 | 買 |
04/17/2023 | 292.52% | BTIG | 100 美元 → 105 美元 | 維護 | 買 |
02/28/2023 | 232.71% | Stephens & Co. | 87 美元 → 89 美元 | 維護 | 超重 |
01/24/2023 | 255.14% | 瑞穗市 | 70 美元 → 95 美元 | 維護 | 買 |
12/28/2022 | 225.23% | Stephens & Co. | 90 美元 → 87 美元 | 維護 | 超重 |
2022 年 10 月 14 日 | 236.45% | Stephens & Co. | → 90 美元 | 恢復 | → 超重 |
2022 年 10 月 13 日 | 161.68% | 瑞穗市 | → 70 美元 | 啓動覆蓋範圍開啓 | → 購買 |
2022 年 7 月 10 日 | 273.83% | BTIG | 90 美元 → 100 美元 | 維護 | 買 |
2022 年 8 月 24 日 | 300% | B. 萊利證券 | → 107 美元 | 啓動覆蓋範圍開啓 | → 購買 |
08/09/2022 | 142.99% | 高盛 | 57 美元 → 65 美元 | 維護 | 中立 |
2022 年 6 月 24 日 | 236.45% | BTIG | 105 美元 → 90 美元 | 維護 | 買 |
05/11/2022 | 113.08% | 高盛 | 67 美元 → 57 美元 | 維護 | 中立 |
04/22/2022 | 311.21% | BTIG | 95 美元 → 110 美元 | 維護 | 買 |
03/21/2022 | 150.47% | 高盛 | 78 美元 → 67 美元 | 維護 | 中立 |
11/10/2021 | 236.45% | Stephens & Co. | 88 美元 → 90 美元 | 維護 | 超重 |
08/03/2021 | 191.59% | 高盛 | 68 美元 → 78 美元 | 維護 | 中立 |
06/23/2021 | 228.97% | BTIG | 82 美元 → 88 美元 | 維護 | 買 |
2021 年 10 月 2 日 | 199.07% | Cowen & Co. | 60 美元 → 80 美元 | 維護 | 跑贏大盤 |
05/14/2020 | -25.23% | 高盛 | → 20 美元 | 啓動覆蓋範圍開啓 | → 中立 |
03/23/2020 | -14.02% | Stephens & Co. | 30 美元 → 23 美元 | 維護 | 超重 |
03/17/2020 | 30.84% | BTIG | 40 美元 → 35 美元 | 維護 | 買 |
2019 年 6 月 28 日 | 8.41% | 富國銀行 | → 29 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
06/07/2019 | 38.32% | Stephens & Co. | → 37 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for Establishment Labs Hldgs (ESTA)?
機構實驗室控股公司(ESTA)的目標價格是多少?
The latest price target for Establishment Labs Hldgs (NASDAQ: ESTA) was reported by Mizuho on November 8, 2023. The analyst firm set a price target for $50.00 expecting ESTA to rise to within 12 months (a possible 86.92% upside). 10 analyst firms have reported ratings in the last year.
瑞穗於2023年11月8日公佈了建制實驗室控股公司(納斯達克股票代碼:ESTA)的最新目標股價。該分析公司將目標股價定爲50.00美元,預計ESTA將在12個月內升至12個月內(可能上漲86.92%)。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Establishment Labs Hldgs (ESTA)?
機構實驗室控股公司(ESTA)的最新分析師評級是多少?
The latest analyst rating for Establishment Labs Hldgs (NASDAQ: ESTA) was provided by Mizuho, and Establishment Labs Hldgs maintained their buy rating.
瑞穗提供了機構實驗室控股公司(納斯達克股票代碼:ESTA)的最新分析師評級,機構實驗室控股維持買入評級。
When is the next analyst rating going to be posted or updated for Establishment Labs Hldgs (ESTA)?
機構實驗室控股公司(ESTA)的下一次分析師評級何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Establishment Labs Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Establishment Labs Hldgs was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括瀏覽公開財務報表,與Exturation Labs Hldgs的高管和客戶交談,以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級,因此每家公司每年應該獲得4次評級。機構實驗室控股的最新評級是在2023年11月8日公佈的,因此您應該預計下一個評級將在2024年11月8日左右公佈。
Is the Analyst Rating Establishment Labs Hldgs (ESTA) correct?
分析師評級機構實驗室控股 (ESTA) 是否正確?
While ratings are subjective and will change, the latest Establishment Labs Hldgs (ESTA) rating was a maintained with a price target of $80.00 to $50.00. The current price Establishment Labs Hldgs (ESTA) is trading at is $26.75, which is out of the analyst's predicted range.
儘管評級是主觀的,並且會發生變化,但機構實驗室控股(ESTA)的最新評級維持不變,目標股價爲80.00美元至50.00美元。機構實驗室控股(ESTA)目前的交易價格爲26.75美元,超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。